Independent education resourceInformation here does not replace care from a qualified health professional.
Peptide Therapy GuideClear peptide education

Educational guide

Dapoxetine Overview, Dosing & Safety | Peptide Database

Dapoxetine (Priligy) SSRI | Premature Ejaculation Treatment Community Research Join others researching Dapoxetine — share findings, ask questions, and learn from real experiences Dapoxetine is the first and only selective serotonin reuptake inhibitor (SSRI) sp

Written by Peptide Therapy Guide Editorial Team
For education only

This guide cannot diagnose a condition or recommend a personal treatment plan. Discuss medical questions with a qualified professional.

Dapoxetine (Priligy)

SSRI | Premature Ejaculation Treatment

Community Research

Join others researching Dapoxetine — share findings, ask questions, and learn from real experiences

Dapoxetine is the first and only selective serotonin reuptake inhibitor (SSRI) specifically developed and approved for the on-demand treatment of premature ejaculation (PE) in men aged 18-64. Unlike conventional SSRIs such as paroxetine or sertraline -- which are sometimes used off-label for PE but require daily dosing and weeks to reach therapeutic effect -- dapoxetine was engineered for rapid absorption and short elimination, making it suitable for as-needed use 1-3 hours before sexual activity. Originally developed by Eli Lilly and later licensed to Johnson & Johnson (ALZA Corporation), dapoxetine received its first regulatory approval in Sweden in 2009 under the brand name Priligy, and has since been approved in over 50 countries across Europe, Asia, Latin America, and the Middle East. It has not received FDA approval in the United States despite multiple submissions. Dapoxetine works by increasing serotonin activity at the postsynaptic cleft in the ejaculatory reflex pathway, raising the threshold for ejaculation and improving control over the timing of climax.

Dapoxetine selectively inhibits the serotonin transporter (SERT) at presynaptic nerve terminals, blocking reuptake of serotonin (5-HT) from the synaptic cleft. This increases serotonin concentration at postsynaptic receptors in the neural circuits governing the ejaculatory reflex, particularly within the spinal ejaculation generator and supraspinal pathways. The ejaculatory process is modulated by serotonergic neurotransmission: higher serotonin levels at 5-HT1B and 5-HT2C receptors raise the ejaculatory threshold, delaying the emission and expulsion phases of ejaculation. Unlike traditional SSRIs that require 1-2 weeks of daily dosing to achieve steady-state serotonin levels, dapoxetine reaches peak plasma concentration within approximately 1-2 hours after oral administration and is rapidly eliminated (terminal half-life ~1.5 hours, with an initial half-life of ~1.4 hours). This pharmacokinetic profile enables acute, on-demand modulation of serotonergic tone without the sustained receptor desensitization seen with chronic SSRI use.

Molecular Data

Research Indications

First-line pharmacotherapy for lifelong and acquired premature ejaculation. Clinically proven to increase intravaginal ejaculatory latency time (IELT), improve perceived control over ejaculation, and reduce personal distress related to PE.

Improved ejaculatory control leads to greater sexual satisfaction for both the individual and their partner, as measured by validated patient-reported outcome instruments in clinical trials.

Dosing Protocols

Dapoxetine is administered orally as a film-coated tablet, taken on-demand 1-3 hours before anticipated sexual activity. It can be taken with or without food, though taking it with food may slightly delay peak plasma concentration. It should be swallowed whole with a full glass of water. Alcohol should be avoided as it may increase the risk of dizziness and syncope.

PE treatment (starting dose)

30mg

As needed, 1-3 hours before sexual activity

Oral

PE treatment (increased dose)

60mg

Interactions

What to Expect

Side Effects & Safety

Common Side Effects

Nausea (11-22%, most common side effect, usually mild and transient)

Dizziness (5-11%)

Headache (5-9%)

Diarrhea (3-7%)

Insomnia (2-4%)

Fatigue (2-4%)

Somnolence (2-3%)

Dry mouth (1-2%)

Stop Signs - Discontinue if:

Syncope or fainting: discontinue and do not re-initiate without medical consultation

Signs of serotonin syndrome: agitation, confusion, rapid heart rate, high body temperature, muscle rigidity, tremor -- seek emergency medical attention

Suicidal thoughts or worsening mood: discontinue and seek immediate psychiatric evaluation

Seizure activity

Severe allergic reaction: difficulty breathing, facial swelling, severe rash

Contraindications

Concurrent use of SSRIs, SNRIs, MAOIs, tricyclic antidepressants, or other serotonergic medications

Use within 14 days of stopping an MAOI or serotonergic antidepressant

Significant cardiac conditions: heart failure (NYHA Class II-IV), conduction abnormalities (second or third degree AV block), ischemic heart disease, significant valvular disease

History of syncope or orthostatic hypotension

Moderate to severe hepatic impairment (Child-Pugh Class B or C)

Known hypersensitivity to dapoxetine or any excipient

Concurrent use of potent CYP3A4 inhibitors at the 60mg dose

Patients under 18 or over 65 years of age (limited safety data)

Quality Checklist

Good Signs

Film-coated tablets with consistent size, shape, and color

Clear labeling with manufacturer, batch number, and expiration date

Blister packaging with tamper-evident seals

Purchased from a licensed pharmacy in a country where dapoxetine is approved

Manufactured by a reputable pharmaceutical company (Menarini, Janssen, or authorized generics)

Warning Signs

Unusually low pricing compared to established products

Tablets varying in appearance within the same package

Packaging with poor print quality, spelling errors, or missing regulatory markings

Sold online without any medical questionnaire or prescription requirement

Products labeled as 'Super Priligy' or similar non-standard naming from unverified sources

Bad Signs

Tablets that are discolored, crumbling, or have an unusual odor

Products from unregulated online pharmacies with no verifiable physical address

No batch number, expiration date, or manufacturer information on packaging

Combination products (dapoxetine + sildenafil/tadalafil) from unregulated sources with no quality assurance

Capsules or liquid formulations (dapoxetine is only approved as a tablet)

Frequently Asked Questions

Can I use dapoxetine with tadalafil for both ED and PE?

Yes. Dapoxetine and tadalafil are frequently co-administered and even co-formulated to address both erectile dysfunction and premature ejaculation simultaneously. The two compounds do not significantly interact pharmacokinetically or pharmacodynamically. However, monitor for additive orthostatic effects (dizziness, blood pressure changes) when combining them, especially on initial use. No dose adjustments are needed, but taking dapoxetine 1-3 hours before sexual activity while using tadalafil for its longer duration (up to 36 hours) is a standard approach.

Why can't I take dapoxetine with my SSRI antidepressant?

Combining dapoxetine with any other SSRI, SNRI, or serotonergic medication creates a serious risk of serotonin syndrome—a potentially life-threatening condition characterized by agitation, confusion, rapid heart rate, high body temperature, muscle rigidity, and tremor. Dapoxetine works by blocking serotonin reuptake, and adding another serotonergic agent dramatically amplifies this effect. If you are taking an SSRI like sertraline or paroxetine for depression or anxiety, you must stop it at least 14 days before starting dapoxetine, and must wait at least 7 days after stopping dapoxetine before starting an SSRI. Discuss alternatives with your doctor.

Will dapoxetine cause a 'hangover' the next day after use?

No. Dapoxetine has an extremely short half-life of approximately 1.5 hours and is rapidly eliminated from the body. Peak effects occur 1-2 hours after dosing and substantially diminish within 4-6 hours. By 12-24 hours post-dose, the drug is effectively cleared with minimal residual serotonergic activity. Most users report no next-day effects or hangover, which is a major advantage of dapoxetine over daily SSRIs used off-label for PE. This rapid clearance is what makes on-demand dosing practical.

How fast does dapoxetine work, and do I need to use it every time?

Dapoxetine works quickly: peak effects occur 1-2 hours after dosing, with maximum benefit typically realized within 2-3 hours. You can see results from the first dose. It is designed for on-demand use only—take one dose 1-3 hours before sexual activity whenever you anticipate needing it. There is no need to use it every time unless you choose to. The maximum dose is one per 24-hour period. Unlike daily SSRIs which require weeks to work and continuous use, dapoxetine gives you the flexibility to dose only when needed, making it ideal for men with situational or lifelong PE who want control without daily medication.

References

Comprehensive review of dapoxetine clinical trial data. Demonstrated that dapoxetine 30mg and 60mg significantly increased IELT (2.5-fold and 3.0-fold, respectively) compared to placebo across five phase III RCTs involving over 6,000 men. Both doses significantly improved perceived control and reduced personal distress.

Pharmacokinetic characterization establishing dapoxetine's unique rapid-absorption/rapid-elimination profile. Peak plasma concentration reached at 1.01 hours (30mg) and 1.27 hours (60mg). Terminal half-life of approximately 1.5 hours with no accumulation on repeat dosing. This profile confirmed suitability for on-demand use.

Pooled analysis of 2,614 men across four pivotal phase III trials. Dapoxetine 30mg and 60mg produced statistically significant increases in mean IELT from baseline (0.9 min at baseline to 2.78 min and 3.32 min, respectively, vs 1.75 min for placebo). Both doses significantly improved patient-reported outcomes for control over ejaculation and satisfaction.

Large multinational phase III study (n=1,238) confirming dapoxetine efficacy across diverse populations. Both 30mg and 60mg doses significantly improved IELT, ejaculatory control, and satisfaction from the first dose onward. Treatment was well tolerated with nausea and dizziness as the most common adverse events.

Disclaimer

This information is for educational and research purposes only. Consult a healthcare professional before use.

Connected reading

Helpful context for this guide

Source-derived material selected through this article’s indexed topics.

comparison

Why is TB-500 dosed 2.5x higher in Tri-Heal Max versus standard Wolverine Stack?

Tri-Heal Max emphasizes TB-500's superior cell migration and angiogenesis properties (25mg vs standard 10mg) for more significant tissue damage. The 2.5:1 ratio targets acute injuries, majo…

Source: peptide-db.com
comparison

What's the dose range for cognitive enhancement versus being too much?

The cognitive 'sweet spot' is 0.5-2 mg/kg body weight (roughly 35-140 mg for a 70 kg person). Doses above 2 mg/kg often shift from antioxidant to pro-oxidant effects, becoming counterproduc…

Source: peptide-db.com
comparison

What's the addiction risk of phenibut vs benzodiazepines?

Phenibut carries similar addiction and withdrawal risk to benzodiazepines despite not being a benzo. Physical dependence can develop in as little as 1-2 weeks of daily use, and withdrawal i…

Source: peptide-db.com
Research context

Read sources and limitations before applying a claim.

Does Cerebrolysin actually work for stroke recovery or is the evidence mixed?

Evidence is mixed. Large meta-analysis of 1,879 stroke patients showed NIHSS (neurological function) superiority, but an independent analysis found no significant improvement in modified Rankin Scale (functional outcomes). Cerebrolysin appears to have early neurological benefits without clear long-term functional recovery advantage.

Source: peptide-db.com ↗

Community Research

Join others researching Adalank — share findings, ask questions, and learn from real experiences Enhanced derivative of Selank with improved stability, blood-brain barrier penetration, and extended half-life compared to parent compound. Parent compound Selank approved in Russia since early 2000s. Modulates GABAergic neurotransmission, upregulates hippocampal BDNF, influences serotonin metabolism, and provides immunomodulatory effects without benzodiazepine-like dependency.

Source: peptide-db.com ↗
Practical and safety references

These excerpts are educational, not personalised medical instructions.

Dosage reference

Dosing Protocols

RU-58841 is used exclusively as a topical solution applied to the scalp. It is not available as a commercial pharmaceutical product. Users typically purchase raw powder and dissolve it in a vehicle such as ethanol, propylene glycol, or a combination of the two. The standard concentration used in the community is 50mg/mL (5%), applied once daily. The solution is applied with a dropper or spray to affected areas of the scalp and allowed to dry. Consistency of daily application is important for maintaining receptor blockade at the follicle. Hair loss treatment (standard community protocol) 50mg (1mL of 50mg/mL solution) Once daily Topical application to affected scalp areas Hair loss treatment (conservative) 25mg (1mL of 25mg/mL solution)

Source: peptide-db.com ↗
Side effects

Common Side Effects

Joint pain and stiffness (generally less severe than with anastrozole due to mild androgenic activity) Fatigue and general malaise Hot flashes or flushing Mood changes (irritability, flat affect, low mood) Headache Increased sweating

Source: peptide-db.com ↗
P

About the author

Peptide Therapy Guide Editorial Team

Editorial team for Peptide Therapy Guide.

View all articles →